NYSE · Medical - Diagnostics & Research

Labcorp Holdings Inc. (LH) Stock

$328.95 -0.30% NYSE: LH Healthcare

Valuation

MetricValue
Price$328.95
Market Cap$26.68B
P/E Ratio25.35
P/B Ratio2.93
P/S Ratio1.76
EPS (TTM)$10.46
52-Week High$341.80
52-Week Low$244.52
Dividend Yield0.93%

Financials & Margins

MetricValue
ROE11.57%
ROA5.41%
ROCE9.86%
Gross Margin10.87%
Operating Margin10.87%
Net Margin6.99%
Debt/Equity0.79
Current Ratio1.42

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.1B$11.9B$12.2B$13.0B$14.0B
Operating Profit$3.0B$1.4B$726.0M$1.1B$1.5B
Net Profit$2.4B$1.3B$418.0M$746.0M$877.0M
EPS$24.38$13.96$4.77$8.84$10.46
Op Margin23.2%12.1%6.0%8.3%10.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.4B$20.2B$16.7B$18.4B$18.4B
Total Liabilities$10.1B$10.0B$8.8B$10.3B$9.8B
Cash$1.5B$321.0M$537.0M$1.5B$532.0M
Borrowings$6.3B$6.2B$6.0B$7.3B$7.2B

Latest News

CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out? Zacks · Jul 15, 2026 New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas 24/7 Wall St. · Jul 13, 2026 Labcorp Declares Quarterly Dividend PR Newswire · Jul 9, 2026 Will Strength in Biotechnology Unit Continue to Drive DHR's Growth? Zacks · Jul 8, 2026 Here's What to Expect From Labcorp Holdings’ Next Earnings Report Barchart · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.1B$2.0B$1.3B$1.6B$1.6B
Investing Cash Flow$-1.3B$-2.1B$-1.6B$-1.9B$-1.6B
Financing Cash Flow$-1.7B$-1.1B$495.0M$23.0M$-496.0M
Net Cash Flow$152.0M$-1.0B$107.0M$982.0M$-986.0M
Free Cash Flow$2.6B$1.5B$874.0M$1.1B$1.2B

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA14.84
FCF Yield4.57%
Quick Ratio1.53
Interest Coverage7.12
Return 1Y17.35%
Return 3Y72.00%
Return 5Y40.46%

Ownership

Insiders Held0.35%
Institutions Held100.98%
Institutions Float Held101.34%
Institutional HolderSharesReport Date
Blackrock Inc.6,444,8562026-03-31
Vanguard Capital Management LLC5,376,1202026-03-31
Victory Capital Management Inc.4,627,1262026-03-31
State Street Corporation3,863,1712026-03-31
Vanguard Portfolio Management LLC3,680,6612026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMXXYbioMérieux S.A. $7.60 -5.35% 21.32 $8.96B 1.45%
DGXQuest Diagnostics Incorporated $241.89 -0.57% 24.45 $26.70B 1.47%
ERFSFEurofins Scientific SE $81.74 +5.24% 27.93 $14.14B 1.03%
GHGuardant Health, Inc. $169.08 +3.77% -46.70 $22.69B 0.00%
GRALGRAIL, Inc. $132.55 +4.32% -14.69 $5.92B 0.00%

About Labcorp Holdings Inc.

Labcorp Holdings Inc. is led by CEO Adam H. Schechter, employs 71,000 people, headquartered in Burlington, US, publicly traded since 1990.

Labcorp Holdings Inc. (LH) stock trades at $328.95 with a market capitalization of $26.68B. The stock is valued at a price-to-earnings (P/E) ratio of 25.35, price-to-book of 2.93, price-to-sales of 1.76. Over the past 52 weeks the stock has ranged between $244.52 and $341.80, and currently trades 3.8% below its 52-week high. It pays a dividend yielding 0.93%.

On profitability, Labcorp Holdings Inc. generates a return on equity (ROE) of 11.57%, return on capital employed of 9.86%, an operating margin of 10.87%, a net profit margin of 6.99%.

In its most recent fiscal year, Labcorp Holdings Inc. reported annual revenue of $14.0B, net profit of $877.0M. Over the last 5 fiscal years, revenue was roughly flat, and net profit declined at an average annual rate of 10.8%.

The balance sheet shows a debt-to-equity ratio of 0.79, a current ratio of 1.42, total assets of $18.4B, $532.0M in cash and equivalents.

LH has an average daily trading volume of 709,016 shares, a beta of 0.85.

Labcorp Holdings Inc. by the numbers, 2016–2025

Between 2016 and 2025 Labcorp Holdings Inc. reported revenue of $9.6B rising to $14.0B, a change of +44.7% across 10 years. Compounded, revenue has grown -0.0% a year over five years, 5.5% over three, 7.3% over the last twelve months. Net profit rose to $877.0M.

Operating margin went from 13.6% in 2016 to 10.9% in 2025, a fall of 2.7 percentage points. The most recent net margin is 6.99%. On a trailing twelve-month basis to Jun '26, revenue is $14.3B and net profit $1.0B.

Borrowings rose from $5.8B to $7.2B, cash from operations was $1.6B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 12.1% over five years, and was 10.2% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Labcorp Holdings Inc. (LH) — frequently asked questions

What is Labcorp Holdings Inc. (LH) stock price today?

Labcorp Holdings Inc. (LH) is currently trading at $328.95, down 0.3% today.

What is LH P/E ratio?

Labcorp Holdings Inc.'s P/E ratio is 25.35. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is LH return on equity (ROE)?

Labcorp Holdings Inc.'s return on equity (ROE) is 11.57%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Labcorp Holdings Inc.'s market cap?

Labcorp Holdings Inc. has a market capitalization of $26.68B.

Does LH pay a dividend?

Yes. Labcorp Holdings Inc. currently yields 0.93%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does LH carry?

Labcorp Holdings Inc. has a debt-to-equity ratio of 0.79. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is LH's profit margin?

Labcorp Holdings Inc. reports a net profit margin of 6.99% — the share of revenue left after every cost, including tax and interest.

What sector is LH in?

Labcorp Holdings Inc. is classified under Healthcare, in the Medical - Diagnostics & Research industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is LH listed on?

Labcorp Holdings Inc. trades on NYSE under the ticker LH.

What is LH's 52-week range?

Over the last year Labcorp Holdings Inc. has traded between $244.52 and $341.80.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens LH currently matches

On the figures above, Labcorp Holdings Inc. passes the filters for 6 of our ready-made screens, among them Large Cap Stocks, Stocks With EPS Above $10, Large Cap Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Large Cap StocksStocks With EPS Above $10Large Cap Dividend StocksNYSE Listed StocksStocks With PE Under 30Debt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.